Abstract cis-Dihydrodiol, cis-tetrahydrodiol and arene hydrate bacterial metabolites, of naphthalene and 1,2-dihydronaphthalene, have been used as synthetic precursors; chemoenzymatic and enzymecatalysed syntheses have been used to obtain all possible enantiopure samples of dihydroxy-1,2,3,4-tetrahydronaphthalene stereoisomers.
Introduction
Bacterial, ring-hydroxylating dioxygenase enzymes have been used extensively in the production of enantiomerically pure cis-1,2-dihydrodiol derivatives of arene substrates. [1] [2] [3] [4] [5] These prokaryotic (cis-diol) metabolites of monosubstituted benzenes, have been widely utilised in the synthesis of a range of alkaloids, sugars and eucaryotic metabolites. [1] [2] [3] [4] [5] The first reported polycyclic arene cisdihydrodiol derivative was cis-1,2-dihydroxy-1,2-dihydronaphthalene 2, formed by dioxygenasecatalysed (Pseudomonas putida) asymmetric dihydroxylation of naphthalene 1. 6 A constitutive mutant strain (UV4), of P. putida, containing toluene dioxygenase (TDO), but without the toluene cis-dihydrodiol dehydrogenase enzyme normally found in wild-type strains, was later used to produce enantiopure (1R,2S)-1,2-dihydroxy-1,2-dihydronaphthalene 2 from naphthalene 1 H-NMR spectroscopy, where an nOe (1%) was recorded between the bridgehead protons H-9b, H-3a and the MeO group. An nOe (3%) was also observed between the bridgehead protons H-9b and H-3a and the Me group of isomer 10A. Due to instability, and the formation of a single product at the next step (10A and 10B → 11), no attempts were made to separate dioxolane isomers 10A and 10B. The crude isomeric mixture 10A / 10B was reacted with chlorotrimethylsilane at 0 ºC in dichloromethane to yield the stable (1S,2S)-chloroacetate derivative 11 ([α] D -30; 72% yield); it was cyclised (NaOMe in THF) to give the corresponding (1R,2S)-epoxide 12 ([α] D + 133; 58% yield). We had earlier reported the synthesis of (+)-(1R,2S)-epoxide 12 via resolution of racemic trans-1-hydroxy-2-bromo-1,2,3,4-tetrahydro-naphthalene, its cyclisation and base-catalysed hydrolysis ( t BuOH-KOH) of the epoxide to yield (-)-(1S,2S)-tetrahydrodiol 13.
(1S,2R)-Tetrahydrodiol 4, of opposite configuration ([α] D + 39)
, was isolated as a minor metabolite, from biotransformation (P. putida UV4) of 1,2-dihydronaphthalene 3 (Scheme 1). When the synthetic sequence 4 → 10A and 10B → 11 → 12 was repeated using (1S,2R) enantiomer of tetrahydrodiol 4, the (1S,2R)-epoxide 12 ([α] D -132), precursor of (+)-(1R,2R)-dihydrodiol 13, was obtained. An alternative approach, involved treatment of (1R,2S)-tetrahydrodiol 4 with methanesulfonyl chloride and triethylamine at -20°C to yield (1R, In contrast with the UV4 mutant strain of P. putida, a source of TDO, the wild-type bacterium P. putida ML2 was found to have both a dioxygenase (benzene dioxygenase) and the corresponding cis-diol dehydrogenase (benzene cis-diol dehydrogenase) enzyme present. [12] [13] [14] GC-MS analysis had earlier confirmed that, in the presence of P. putida ML2, a series of acyclic and cyclic vic. diol substrates were oxidized to the corresponding ketoalcohols (ketols). [12] [13] [14] These were in turn found to be reduced enzymatically to yield both acyclic vic-diols 12 and monocyclic trans-diols 14 using P. putida ML2; thus, the meso substrate cis-1,2-dihydroxycyclohex-4-ene gave the corresponding ketoalcohol and enantiopure trans-diol. 14 A similar type of whole cell biotransformation has been reported, 15 using cis-1,2-dihydroxycyclohexane as substrate and the fungus Corynesporia cassiicola, to yield the corresponding trans-diol (>99% ee).
As part of a programme to evaluate the wider potential of enzymes from P. putida ML2, in the production of enantiopure trans-dihydrodiols from meso cis-dihydrodiol substrates, 14 a preliminary small-scale experiment was carried out with cis-diol substrate 9 (concentration 2 g/L, 5 h). GC-MS analysis, of the crude mixture of bioproducts, showed, that cis-diol substrate 9 (35%), ketoalcohol 19 (15%), trans diol 18 (35%), and a further unidentified bioproduct (15%) were present. When the biotransformation was repeated, on a larger scale, using a higher substrate concentration (4 g /L) and an extended biotransformation period (24 h), only the unreacted cis-diol substrate 9 and trans-diol bioproduct 18, in equal ratio, were detected and isolated. Separation of trans-diol 18 was achieved by conversion of the residual cis-diol 9, present in the cis / trans mixture, to the corresponding acetonide derivative followed by separation of the reaction mixture by flash chromatography. These biotransformations indicated that ketol 19 was a better substrate than cis-diol 9; it was completely reduced to trans-diol 18 ([α] D + 90, EtOH; 30% isolated yield) after being in contact with the enzyme system for the longer period. Formation of the di-2-methoxy-2-trifluoromethyl-2-phenylacetate (diMTPA) derivative of diol 18 confirmed that it was enantiopure (>98%) and of the (2S,3S) absolute configuration. A similar stereoselective (>98% ee) cis / trans stereoinversion process has, thus, been observed with the meso cis-diol substrates derived from cyclohexene (with C. cassiicola), 15 1,4-cyclohexadiene (with P. putida ML2), 14 and now 1,4-dihydronaphthalene (with P. putida ML2). The latter single-step enzyme-catalysed asymmetric synthesis of (2S,2S)-2,3-dihydroxy-1,2,3,4-tetrahydronaphthalene 18, from achiral cis-diol substrate 9 (Scheme 3), provides a more convenient alternative approach to the multistep chemoenzymatic routes to the (2R,3R) enantiomer reported earlier 9 or shown in Scheme 3 (2→15→16→17→18).
Arene hydrates of naphthalene (5, 7 and 8), available from biotransformation (P. putida UV4) of 1,2-(3) and 1,4-dihydronaphthalene (6) (Scheme 1), 7 have not, to date, been used as chiral synthetic precursors. 
Experimental Section
General Procedures.
1
H NMR spectra were recorded at 300 MHz (Bruker Avance DPX-300) and 500 MHz (Bruker Avance DRX-500) in CDCl 3 solvent unless stated otherwise. Chemical shifts (δ) are reported in ppm relative to SiMe 4 and coupling constants (J) are given in Hz. Mass spectra were recorded at 70eV on a VG Autospec Mass Spectrometer, using a heated inlet system. Accurate molecular weights were determined by the peak matching method with perfluorokerosene as standard. Elemental microanalyses were obtained on a Perkin-Elmer 2400 CHN microanalyser. HPLC analyses were carried out using a Perkin-Elmer Series 3B liquid chromatograph coupled to a Perkin-Elmer LC1-100 computing integrator. Analytical TLC was performed on Merck Kieselgel 60 254 plastic sheets and preparative TLC (PLC) on glass plates (20 cm x 20 cm) coated with Merck Kieselgel PF 254+366 .
The biotransformations of naphthalene 1 and 1,2-dihydronaphthalene 3, using P. putida UV4, and isolation of enantiopure (1R, were available from earlier studies. The biotransformation conditions, used for P. putida ML2 and 1,4-dihydronaphthalene 6 were very similar to those reported. 12, 13 cis-2,3-Dihydroxy-1,2,3,4-tetrahydronaphthalene (9). 1,4-Dihydronaphthalene 6 (9 g, 69 mmol) was added to a mixture of dichloromethane (500 cm 3 ) and water (8 cm 3 ) containing trimethylamine N-oxide (7.66 g, 69 mmol. 1R,2R)-and (1S,2S)-1,2-dihydroxy-1,2,3,4-tetrahydro-naphthalene (13)  (-)-(1R,2S)-1,2-Dihydroxy-1,2,3,4-tetrahydronaphthalene (4). (1R,2S) (1R,2S) and (-)-(1S,2R)-1,2-Epoxy-l,2,3,4-tetrahydronaphthalene (12) . Sodium methoxide (0.5 g, 13 mmol) was added, to a solution of (1S,2S)-2-acetoxy-l-chloro-l,2,3,4-tetrahydronaphthalene 11 (0. (-)-(1S,2R)-1,2-Epoxy-1,2,3,4-tetrahydronaphthalene (12) . To a solution of dimesylate 14 (+)-(1R,2S,3R,4R)-1,2-Diacetoxy-3,4-epoxy-1,2,3,4-tetrahydro-naphthalene (16 (-)-(2R,3R)-2,3-Dihydroxy-1,2,3,4-tetrahydronaphthalene (18) . Ammonia gas was bubbled (1 h) through a solution of (2R,3R)-2-acetoxy-3-hydroxy-l,2,3,4-tetrahydronaphthalene 17 (0.030 g, 0.14 mmol), in methanol (5 cm 3 ) maintained at 0 °C. (+)-(2S,3S)-2,3-Dihydroxy-1,2,3,4-tetrahydronaphthalene (18 (1R,3S)-l,3-Dihydroxy-1,2,3 
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